Atlas Trials

A Prospective, Global, Multi-center, Treatment Registry Study of Intravenous Immunoglobulin Maintenance Therapy in Alloantibody Positive Renal Allograft Recipients

Clinical trial NCT02115503 · TERMINATED

Trial details

NCT number
NCT02115503
Sponsor
Databean
Status
TERMINATED
Study type
OBSERVATIONAL
Renal Transplant Recipients With Anti-HLA Antibodies
Start date
2014-07-01
Primary completion
2019-08-01
Enrollment
52

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.